Clinical trials: Thrombosis, Venous
Venous Thromboembolic Disease, Respiratory Disease
Screening for Cancer in Patients With Unprovoked VTE
Open and multicenter randomized clinical trial (1:1) comparing limited screening with extended screening with the performance of Positron emission tomography-computed tomography (PET-CT) scan in the search for neoplasms in…
- Conditions
- Venous Thromboembolic Disease, Respiratory Disease, Pulmonary Disease, Deep Venous Thrombosis
- Trial name
- SOME-RIETE (NCT03937583)
- Testing
- Fludeoxyglucose 18F
- Where
- 17 sites in Spain
- Volunteers
- 650 people
- Sponsor
- Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Circadian Variation in Anti-Factor Xa (Anti-FXa) Activity
Circadian Variation of Anti-Factor Xa in Hospitalized Trauma Patients
The purpose of this study is to determine whether a circadian rhythm exists in anti-FXa levels and AT3 activity in hospitalized trauma patients receiving low-molecular-weight heparin (LMWH) chemoprophylaxis
- Trial name
- NCT07856641
- Where
- United States
- Volunteers
- 40 people
- Sponsor
- The University of Texas Health Science Center, Houston
Venous Thromboembolism
Replication of the EINSTEIN-DVT Anticoagulant Trial in Healthcare Claims Data
Investigators are building an empirical evidence base for real world data through large-scale replication of randomized controlled trials.
- Trial name
- NCT04736420
- Testing
- Rivaroxaban, Warfarin
- Where
- United States
- Volunteers
- 78,605 people
- Sponsor
- Brigham and Women's Hospital
Venous Thromboembolism, Venous Thromboses
TRanEXamic Acid to Decrease Heavy Menstrual Bleeding in Individuals Anticoagulated for Venous Thromboembolism Pilot Study
T-REX HMB is a pilot randomized controlled trial (RCT) designed to assess the feasibility of a full trial comparing tranexamic acid (TXA) to placebo in decreasing HMB in premenopausal individuals anticoagulated for VTE.
- Conditions
- Venous Thromboembolism, Venous Thromboses, Heavy Menstrual Bleeding, Anticoagulants and Bleeding Disorders
- Trial name
- T-REX HMB (NCT06452342)
- Testing
- Tranexamic acid, No Tranexamic acid
- Volunteers
- 20 people
- Sponsor
- University Health Network, Toronto
Deep Vein Thrombosis, Pulmonary Embolus
Inferior Vena Cava Filters: Analysis of a Database
In this study a retrospective analysis of patients database was performed, who underwent treatment for deep vein thrombosis in tertiary hospital by using inferior vena cava-filters
- Trial name
- NCT04330170
- Where
- Russia
- Volunteers
- 2,399 people
- Sponsor
- Pirogov Russian National Research Medical University
Venous Thromboembolism, Pulmonary Thromboembolisms
Time of Treatment With LMWH in Cancer Patients With Thromboembolic Disease
Cancer is the most important acquired risk factor of thromboembolisms. More than 20% of all episodes of venous thromboembolism (VT) or pulmonary thromboembolisms (PT) are cancer related.
- Conditions
- Venous Thromboembolism, Pulmonary Thromboembolisms, Cancer
- Trial name
- NCT03134820
- Volunteers
- 352 people
- Sponsor
- Delos Clinical
Retinal Vein Occlusion
Continuing Assessment of Patients Treated With ranibizUmab for REtinal Vein Occlusion (CAPTURE)
This research is being done to assess the long term prognosis of patients treated with ranibizumab for edema due to retinal vein occlusion.
- Trial name
- CAPTURE (NCT01875770)
- Where
- United States
- Volunteers
- 47 people
- Sponsor
- Johns Hopkins University
Venous Thromboembolism
An Observational Study On The Safety And Tolerability Of Prolonged Thrombosis Prophylaxis With Fragmin®
The objective of this study is to observe the safety, tolerability, and compliance in the use of Fragmin® for prolonged thromboprophylaxis in post-surgery high-risk orthopedic patients.
- Trial name
- NCT01046903
- Testing
- Fragmin® (Dalteparin Sodium)
- Volunteers
- 503 people
- Sponsor
- Pfizer
Osteoarthritis, Deep Venous Thrombosis
Exercise and Cycle Ergometry Post TKA - A Randomized Controlled Trial
The purpose of this investigation is to examine the effect of, and improve patient compliance and motivation following total knee arthroplasty; to determine the efficacy of two post-surgical exercise programs on knee pain…
- Trial name
- NCT02265523
- Testing
- Cycle ergometer
- Where
- Canada
- Volunteers
- 55 people
- Sponsor
- Lakehead University
Chronic Venous Thrombosis, Venous Thrombosis Upper Extremity
Surfacer System to Facilitate Access in Venous Occlusions
Prospective, single-arm, multicentre, international Registry of the Surfacer System for the treatment of patients with limited or diminishing upper body venous access or pathology impeding standard access methods.The purpose of…
- Conditions
- Chronic Venous Thrombosis, Venous Thrombosis Upper Extremity, Venous Thrombosis Upper Extremity Superficial Veins
- Trial name
- SAVE (NCT02875899)
- Where
- 4 sites in Austria, Germany and 1 more
- Volunteers
- 30 people
- Sponsor
- Merit Medical Systems, Inc.
Hematoma Postoperative, Venous Thromboembolism
Use of Tranexamic Acid in Reduction Mammoplasty
Breast reduction mammoplasty (BRM) is among the most commonly performed procedures in plastic surgery. However, postoperative hematoma is one of the most common complications following BRM.
- Trial name
- TREX-ARM (NCT04947514)
- Testing
- Tranexamic acid
- Where
- United States
- Volunteers
- 98 people, healthy volunteers welcome
- Sponsor
- Montefiore Medical Center
Morbid Obesity, Thromboembolism
Prophylaxis of Venous Thromboembolism After Bariatric Surgery
This study is a prospective evaluation of the relationship between lean body weight and anti-Xa activity and 5700 International Units (IU) nadroparin 4 hours after subcutaneous administration in morbidly obese patients after…
- Conditions
- Morbid Obesity, Thromboembolism, Bypass Complications
- Trial name
- NCT02295150
- Testing
- Nadroparin
- Where
- Netherlands
- Volunteers
- 50 people
- Sponsor
- Rijnstate Hospital
Rivaroxaban, Thromboprophylaxis
Rivaroxaban for Thromboprophylaxis in High-risk Cancer Patients With Totally Implantable Access Ports
Rivaroxaban has been developed in the various clinical settings.Although cancer-associated DVT or PE was included in previously programs, limited patients of the total populations were cancer patients with totally implantable…
- Conditions
- Rivaroxaban, Thromboprophylaxis, Cancer
- Trial name
- NCT04309240
- Testing
- Rivaroxaban
- Volunteers
- 204 people
- Sponsor
- LiuZhou People's Hospital
Venous Thromboembolism (VTE), Deep Vein Thrombosis (DVT)
Cancer Venous Thromboembolism (VTE)
The primary objective is to demonstrate the non-inferiority of edoxaban (preceded by a short course of LMWH) compared with dalteparin for the prevention of the combined outcome of recurrent venous thromboembolism (VTE) or major…
- Conditions
- Venous Thromboembolism (VTE), Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Cancer
- Trial name
- NCT02073682
- Testing
- Edoxaban, Dalteparin, Low molecular weight heparin
- Where
- 9 sites in United States, Belgium and 4 more
- Volunteers
- 1,046 people
- Sponsor
- Daiichi Sankyo
Thromboembolism, Venous
Evaluation of Chemical Venous Thromboembolism Prophylaxis in Trauma
Venous thromboembolism (VTE) causes up to 100,000 deaths annually. Between 10%-30% of patients die within one month of VTE diagnosis, while survivors remain at increased risk for VTE recurrence or other complications like…
- Trial name
- NCT06025162
- Testing
- enoxaparin
- Where
- United States
- Volunteers
- 100 people
- Sponsor
- Methodist Health System
Deep Vein Thrombosis
The STOP CLOT Pilot Study: Study of Low Molecular Weight Heparin in High Risk Cesarean Section
Venous thromboembolism (VTE) remains the most common cause of maternal death in the developed world. VTE includes two conditions, deep vein thrombosis (DVT) and pulmonary embolism (PE).
- Trial name
- NCT00225108
- Testing
- Tinzaparin
- Where
- Canada
- Volunteers
- 30 people
- Sponsor
- Ottawa Hospital Research Institute
Advanced Gastric Cancer
Venous Thromboembolism in Advanced Gastric Cancer Patients
Venous thromboembolism (VTE), which includes pulmonary embolism (PE) and deep vein thrombosis (DVT), is a common complication and leading cause of death in cancer patients.
- Trial name
- NCT01047618
- Where
- South Korea
- Volunteers
- 259 people
- Sponsor
- Asan Medical Center
Deep Vein Thrombosis, Pulmonary Embolism
Thromboprophylaxis for Patients Undergoing Surgical Resection for Colon Cancer
The blood thinner "tinzaparin" might increase survival in patients with colon cancer undergoing surgical resection. The investigators want to assess if a trial allocating patients to prolonged treatment with tinzaparin versus…
- Conditions
- Deep Vein Thrombosis, Pulmonary Embolism, Cancer
- Trial name
- PERI-OP (NCT00967148)
- Testing
- Tinzaparin
- Where
- Canada
- Volunteers
- 18 people
- Sponsor
- Ottawa Hospital Research Institute
Catheter Thrombosis, Post Thrombotic Syndrome
Incidence and Characteristic of CRT Persistent After Catheter Extraction in ICU Patients
The goal of this observational study is to describe characteristics of catheter related thrombosis (CRT) that persists after catheter extraction in condition of intensive care unit. The main questions it aims to answer are: 1.
- Conditions
- Catheter Thrombosis, Post Thrombotic Syndrome, Pulmonary Embolism (Diagnosis)
- Trial name
- CRT-PERSIST (NCT07473284)
- Testing
- No Interventions
- Volunteers
- 300 people
- Sponsor
- Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s.
Retinal Vein Occlusion
Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Retinal Vein Occlusion
Open-label, dose ascending safety, tolerability, and proof of concept study to evaluate the use of ANXV (human recombinant Annexin A5) in the treatment of subjects with recently diagnosed Retinal Vein Occlusion.
- Trial name
- NCT05532735
- Testing
- ANXV
- Where
- 7 sites in United States
- Volunteers
- 16 people
- Sponsor
- Annexin Pharmaceuticals AB
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.